From: Genomic profiling of Chinese patients with urothelial carcinoma
Patient number | Genomic alterations in tissue, number | Genomic alterations in blood, number | Genes altered in both samples, number (%) | Genomic alterations in both samples, number (%) |
---|---|---|---|---|
P003 | 6 | 5 | 5 (83.3%) | 5 (83.3%) |
P009 | 2 | 7 | 2 (28.57%) | 2 (28.57%) |
P020 | 0 | 10 | 0 | 0 |
P024 | 2 | 2 | 0 | 0 |
P035 | 1 | 1 | 1 (100%) | 1 (100%) |
P043 | 4 | 3 | 0 | 0 |
P053 | 5 | 9 | 5 (62.5%) | 3 (27.27%) |
P054 | 4 | 4 | 4 (100%) | 4 (100%) |
P071 | 3 | 4 | 2 (50%) | 2 (40%) |
P072 | 3 | 3 | 3 (100%) | 3 (100%) |
P073 | 3 | 3 | 3 (100%) | 3 (100%) |
P074 | 15 | 10 | 4 (36.36%) | 6 (30%) |
P077 | 5 | 5 | 4 (66.67%) | 4 (66.67%) |
P084 | 17 | 4 | 2 (13.33%) | 2 (9.52%) |
P095 | 4 | 7 | 4 (57.14%) | 4 (57.14%) |
P096 | 4 | 1 | 0 | 0 |
P109 | 9 | 11 | 7 (63.64%) | 7 (63.64%) |
P110 | 3 | 1 | 1 (50%) | 1 (33.33%) |
P111 | 4 | 0 | 0 | 0 |
P112 | 5 | 1 | 1 (25%) | 1 (20%) |